Učitavanje...
Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
Although available data are conflicting, psoriasis seems to be associated with an increased baseline risk of malignancy. In addition, some antipsoriatic systemic treatments have been associated with risk of malignancy. There is not enough data on the association of interleukin (IL)-17 and IL-23 inhi...
Spremljeno u:
| Izdano u: | Case Rep Dermatol |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816125/ https://ncbi.nlm.nih.gov/pubmed/31662733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501993 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|